Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Nooms GLP-1 Care Gap white paper delves into the health and cost risks of the GLP-1 care gap, and explores how Nooms programs enhance health outcomes and cost savings, including for those on GLP-1s or other anti-obesity medications
Supplied as a precision-lyophilized peptide of high analytical purity for controlled laboratory use only
Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications primarily prescribed for type 2 diabetes management and, more recently, for chronic weight management
All average concentrations were higher than those in the plasma
Fresenius Kabi
US$ 27.44
US$ 28.26
US$ 27.28
